HCA Healthcare, Inc. (NYSE:HCA) Shares Acquired by Scissortail Wealth Management LLC

Scissortail Wealth Management LLC lifted its stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 77,825.0% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 6,234 shares of the company's stock after acquiring an additional 6,226 shares during the quarter. Scissortail Wealth Management LLC's holdings in HCA Healthcare were worth $1,871,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in HCA. Norges Bank bought a new position in shares of HCA Healthcare during the 4th quarter valued at approximately $840,286,000. Royal London Asset Management Ltd. raised its holdings in HCA Healthcare by 62.0% during the 4th quarter. Royal London Asset Management Ltd. now owns 1,500,786 shares of the company's stock valued at $450,461,000 after buying an additional 574,239 shares during the period. Barclays PLC boosted its stake in shares of HCA Healthcare by 85.7% during the fourth quarter. Barclays PLC now owns 1,061,891 shares of the company's stock valued at $318,727,000 after purchasing an additional 489,916 shares during the period. Principal Financial Group Inc. boosted its stake in shares of HCA Healthcare by 120.1% during the fourth quarter. Principal Financial Group Inc. now owns 873,775 shares of the company's stock valued at $262,264,000 after purchasing an additional 476,756 shares during the period. Finally, Consulta Ltd boosted its stake in shares of HCA Healthcare by 100.0% during the fourth quarter. Consulta Ltd now owns 550,000 shares of the company's stock valued at $165,082,000 after purchasing an additional 275,000 shares during the period. 62.73% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several brokerages have recently commented on HCA. Guggenheim began coverage on HCA Healthcare in a research note on Wednesday, April 9th. They set a "neutral" rating on the stock. Bank of America cut their target price on HCA Healthcare from $380.00 to $370.00 and set a "buy" rating on the stock in a research note on Monday, January 27th. Royal Bank of Canada cut their target price on HCA Healthcare from $384.00 to $376.00 and set an "outperform" rating on the stock in a research note on Monday, April 28th. Baird R W lowered HCA Healthcare from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, April 15th. Finally, Barclays dropped their price target on HCA Healthcare from $392.00 to $366.00 and set an "overweight" rating on the stock in a research note on Monday, January 27th. One research analyst has rated the stock with a sell rating, six have given a hold rating, twelve have issued a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $381.13.

HCA Healthcare Price Performance

Shares of HCA stock traded down $0.94 during trading hours on Tuesday, hitting $385.95. 1,361,442 shares of the company's stock were exchanged, compared to its average volume of 1,435,007. The firm has a market cap of $92.85 billion, a P/E ratio of 17.57, a P/E/G ratio of 1.10 and a beta of 1.46. The firm has a 50 day moving average of $342.18 and a two-hundred day moving average of $328.51. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $417.14.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings results on Friday, April 25th. The company reported $6.45 earnings per share for the quarter, beating analysts' consensus estimates of $5.75 by $0.70. The firm had revenue of $18.32 billion for the quarter, compared to analyst estimates of $18.26 billion. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. HCA Healthcare's quarterly revenue was up 5.7% compared to the same quarter last year. During the same period last year, the company posted $5.36 EPS. Sell-side analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, June 30th. Investors of record on Monday, June 16th will be paid a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a yield of 0.75%. The ex-dividend date of this dividend is Monday, June 16th. HCA Healthcare's dividend payout ratio is presently 12.81%.

Insiders Place Their Bets

In other HCA Healthcare news, COO Jon M. Foster sold 15,698 shares of the firm's stock in a transaction that occurred on Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total value of $5,797,585.36. Following the transaction, the chief operating officer now directly owns 12,646 shares of the company's stock, valued at $4,670,420.72. This trade represents a 55.38% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 1.30% of the company's stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.